PROK1 and preeclampsia: It reduces demyelination in Experimental Autoimmune Encephalomyelitis (EAE), a mouse model of multiple sclerosis [105], and it appears to be useful in the treatment of pregnancy disorders such as preeclampsia and fetal growth restriction associated with abnormal PK1 expression.